Type 2 Diabetes (T2D) Clinical Trials

Find Type 2 Diabetes (T2D) Clinical Trials Near You

KETO-SENSE - Effects of Ketone Bodies on Insulin Sensitivity

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

KETO-SENSE is a clinical research study investigating how ketone bodies affect energy metabolism and insulin sensitivity in humans. Ketone bodies are naturally produced by the liver during fasting or prolonged exercise and can serve as an alternative fuel for the brain, heart, and muscles. In this study, ten overweight but otherwise healthy adults aged 55-70 years will participate in four study days at Aarhus University Hospital. Participants will receive one of four interventions in a randomized crossover design: 1) growth hormone (GH) and a ketone supplement, 2) GH and placebo, 3) a saline infusion with the ketone supplement, or 4) placebo (saline infusion and placebo supplement). The study uses advanced PET/CT imaging, indirect calorimetry, and tissue biopsies to measure how ketones influence fat breakdown, glucose uptake, and energy expenditure. By understanding these mechanisms, the study aims to clarify whether oral ketone supplementation can improve insulin sensitivity and energy metabolism - findings that could be relevant for common conditions such as overweight, insulin resistance, and type 2 diabetes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 55
Maximum Age: 70
Healthy Volunteers: t
View:

• Age range: 55-70 yr

• BMI: 25 - 35 kg/m2

Locations
Other Locations
Denmark
Aarhus University Hospital
RECRUITING
Aarhus N
Contact Information
Primary
Simon Bøggild Hansen, MD
simhan@clin.au.dk
+45 4111 1574
Time Frame
Start Date: 2025-12-02
Estimated Completion Date: 2028-04
Participants
Target number of participants: 10
Treatments
Experimental: GH infusion + oral ketone supplement
Participants receive a continuous intravenous infusion of growth hormone (30 ng·kg-¹·min-¹) combined with oral ketone supplementation.
Experimental: GH infusion + oral placebo
Participants receive a continuous intravenous infusion of growth hormone (30 ng·kg-¹·min-¹) combined with oral placebo
Experimental: Saline infusion + oral ketone supplement
Participants receive an intravenous saline infusion combined with oral ketone supplementation.
Placebo_comparator: Saline infusion + oral placebo
Participants receive a continuous intravenous infusion of saline combined with oral placebo
Related Therapeutic Areas
Sponsors
Leads: University of Aarhus

This content was sourced from clinicaltrials.gov